XTLB

1.9600.00%

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

LongbridgeAII'm LongbridgeAI, I can summarize articles.

In Tuesday's pre-market session, several healthcare stocks showed significant movement. NextCure surged 305.5% to $8.84, while Shuttle Pharmaceuticals rose 72.93%. Other gainers included Picard Medical, Ensysce Biosciences, Bluejay Diagnostics, and Polyrizon. On the losing side, Matinas BioPharma dropped 19.8%, followed by declines in Evotec, XTL Biopharmaceuticals, Trevi Therapeutics, China Pharma Holding, and CNS Pharmaceuticals.

Gainers

  • NextCure (NASDAQ:NXTC) shares rose 305.5% to $8.84 during Tuesday's pre-market session. The market value of their outstanding shares is at $7.8 million.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) stock moved upwards by 72.93% to $5.12. The market value of their outstanding shares is at $1.7 million.
  • Picard Medical (AMEX:PMI) shares increased by 23.43% to $0.18. The company's market cap stands at $14.6 million.
  • Ensysce Biosciences (NASDAQ:ENSC) stock rose 16.15% to $0.32. The company's market cap stands at $4.2 million.
  • Bluejay Diagnostics (NASDAQ:BJDX) shares rose 14.75% to $1.4. The market value of their outstanding shares is at $1.2 million.
  • Polyrizon (NASDAQ:PLRZ) stock rose 14.35% to $15.85. The company's market cap stands at $28.8 million.

Losers

  • Matinas BioPharma Hldgs (AMEX:MTNB) shares decreased by 19.8% to $0.38 during Tuesday's pre-market session. The market value of their outstanding shares is at $3.0 million.
  • Evotec (NASDAQ:EVO) stock fell 13.59% to $2.1. The company's market cap stands at $863.8 million.
  • XTL Biopharmaceuticals (NASDAQ:XTLB) shares decreased by 12.16% to $2.53. The market value of their outstanding shares is at $7.0 million.
  • Trevi Therapeutics (NASDAQ:TRVI) shares fell 12.11% to $14.52. The market value of their outstanding shares is at $2.3 billion.
  • China Pharma Holding (AMEX:CPHI) stock declined by 11.61% to $0.55. The company's market cap stands at $25.3 million.
  • CNS Pharmaceuticals (NASDAQ:CNSP) shares declined by 11.6% to $4.5. The market value of their outstanding shares is at $7.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Login to unlock958characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.